On 9 July 2025, Wuhan Dazhong Dental Medical Co., Ltd. (2651.HK, Dazhong Dental) successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx), raising a total of approximately HKD 217 million. CBI is honored to participate in the due diligence work for this IPO Project.

Dazhong Dental is a China-based company that mainly provides dental medical services. The Company's main businesses include general dentistry services, implantology services and orthodontics services, which are provided under the company’s brand, Aishang Dazhong Dental.

In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the company group, its directors, senior management, shareholders, suppliers and customers. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting reputation intelligence and related company search. The project mainly covers due diligence in China and Hong Kong.